Angiomed

Acquired By CR Bard
Medical devices are developed by Angiomed for vascular applications.
Request Access
Report Incorrect Data
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Angiomed

  • Sectors
    Healthcare
  • Phone
    *********
Operational Areas
Healthcare → Medical Devices & Diagnostics → →
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
    CR Bard
  • Employee Count
    Employee Count
  • Acquired by
    CR Bard

    (Oct 09, 1994)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Angiomed

Investors in Angiomed

Angiomed has secured backing from 1 investor. Prominent investors backing the company include CR Bard.

All
Investor Description Founded Year Domain Location
CR Bard
Products for vascular, urology, oncology, and surgical specialties
Founded Year Domain Location

Investments & Acquisitions by Angiomed

Investments

Financial Statements - Angiomed

Angiomed Comparisons

+
Add Comparison
Available on Premium

Competitors of Angiomed

Latest news on Angiomed

Frequently Asked Questions about Angiomed

Medical devices are developed by Angiomed for vascular applications.

Angiomed has 1 investor. Key investors include CR Bard.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available